AXSM - Axsome Therapeutics, Inc.


164.08
0.030   0.018%

Share volume: 428,584
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$164.05
0.03
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-06-2024 08-05-2024 11-12-2024 02-18-2025 05-05-2025 08-04-2025 11-03-2025 02-23-2026
Total revenue 74.999 M 87.166 M 104.762 M 118.766 M 121.463 M 150.042 M 170.992 M 195.999 M
Cost of revenue 6.297 M 8.055 M 8.437 M 10.514 M 9.789 M 13.448 M 11.912 M 12.329 M
Gross profit 68.702 M 79.111 M 96.325 M 108.252 M 111.674 M 136.594 M 159.080 M 183.670 M
    15.15% 21.76% 12.38% 3.16% 22.31% 16.46% 15.46%  
Operating expenses 135.800 M 153.407 M 140.952 M 168.277 M 165.572 M 179.821 M 190.397 M 218.088 M
Selling general and admin 98.970 M 103.554 M 95.564 M 113.271 M 120.787 M 130.280 M 150.235 M 169.297 M
Research and development 36.830 M 49.853 M 45.388 M 55.006 M 44.785 M 49.541 M 40.162 M 48.791 M
Total expenses 135.977 M 157.157 M 158.949 M 180.869 M 168.656 M 173.308 M 205.189 M 210.627 M
    15.58% 1.14% 13.79% -6.75% 2.76% 18.40% 2.65%  
Operating income -67.275 M -78.046 M -62.624 M -72.617 M -56.982 M -36.714 M -46.109 M -26.957 M
Ebit -67.275 M -78.046 M -62.624 M -72.617 M -56.982 M -36.714 M -46.109 M -26.957 M
Pretax income -68.357 M -79.345 M -64.602 M -74.827 M -59.413 M -48.933 M -47.229 M -28.129 M
    16.07% -18.58% 15.83% -20.60% -17.64% -3.48% -40.44%  
Income tax 0.000 0.000 0.000 85.000 K 0.000 -960.000 K 0.000 430.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -68.357 M -79.345 M -64.602 M -74.912 M -59.413 M -47.973 M -47.229 M -28.559 M
    -16.07% 18.58% -15.96% 20.69% 19.26% 1.55% 39.53%